Voglio sapere a riguardo di…

7402

Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices
of automated collection techniques or other forms of information technology to minimize the information collection burden.
DATES: Comments on the collections of information must be received by the OMB desk officer by March 1, 2021.
ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/
PRAMain. Find this particular information collection by selecting Currently under 30-day ReviewOpen for Public Comments or by using the search function.
To obtain copies of a supporting statement and any related forms for the proposed collections summarized in this notice, you may make your request using one of following:
1. Access CMS website address at website address at https www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Call the Reports Clearance Office at 410 7861326.
FOR FURTHER INFORMATION CONTACT:
William Parham at 410 7864669.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 PRA
44 U.S.C. 35013520, federal agencies must obtain approval from the Office of Management and Budget OMB for each collection of information they conduct or sponsor. The term collection of information is defined in 44 U.S.C.
35023 and 5 CFR 1320.3c and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506c2A of the PRA 44 U.S.C.
3506c2A requires federal agencies to publish a 30-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice that summarizes the following proposed collections of information for public comment:
1. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Disclosure Requirement for the In-Office Ancillary Services Exception; Use: Section 6003 of the Affordable Care Act ACA
established a new disclosure requirement that a physician must perform for certain imaging services to meet the in-office ancillary services
VerDate Sep<11>2014

17:16 Jan 27, 2021

Jkt 253001

exception to the prohibition of the physician self-referral law. This section of the ACA amended section 1877b2
of the Act by adding a requirement that the referring physician informs the patient, at the time of the referral and in writing, that the patient may receive the imaging service from another supplier.
Physicians who provide certain imaging services MRI, CT, and PET
under the in-office ancillary services exception to the physician self-referral prohibition are required to provide the disclosure notice as well as the list of other imaging suppliers to the patient.
The patient will then be able to use the disclosure notice and list of suppliers in making an informed decision about his or her course of care for the imaging service.
CMS would use the collected information for enforcement purposes.
Specifically, if we were investigating the referrals of a physician providing advanced imaging services under the inoffice ancillary services exception, we would review the written disclosure in order to determine if it satisfied the requirement. Form Number: CMS
10332 OMB control number: 0938
1133; Frequency: Occasionally;
Affected Public: Private Sector, Business or other for-profits, Not-for-profits institutions; Number of Respondents:
2,239; Total Annual Responses:
989,971; Total Annual Hours: 18,694.
For questions regarding this collection contact Laura Dash at 4107868623.
Dated: January 25, 2021.
William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs.
FR Doc. 202101896 Filed 12721; 8:45 am BILLING CODE 412001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services Administration Meeting of the Advisory Committee on Childhood Vaccines Health Resources and Services Administration HRSA, Department of Health and Human Services HHS.
ACTION: Notice.
AGENCY:

In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Childhood Vaccines ACCV will hold public meetings for the 2021 calendar year CY.
Information about the ACCV, agendas, and materials for these meetings can be
SUMMARY:

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

found on the ACCV website at https
www.hrsa.gov/advisory-committees/
vaccines.
ACCV meetings will be held on:
March 4, 2021, 10:00 a.m. Eastern Time ET4:00 p.m. ET;
June 3, 2021, 10:00 a.m. ET4:00
p.m. ET;
September 2, 2021, 10:00 a.m. ET
4:00 p.m. ET;
December 2, 2021, 10:00 a.m. ET
4:00 p.m. ET.
ADDRESSES: Meetings may be held inperson or by teleconference and webinar. For updates on how the meeting will be held, visit the ACCV
website 30 business days before the date of the meeting, where instructions for joining meetings either in-person and remotely will also be posted. In-person ACCV meetings will be held at 5600
Fishers Lane, Rockville, Maryland 20857. For meeting information updates, go to the ACCV website listed above.
FOR FURTHER INFORMATION CONTACT:
Annie Herzog, Division of Injury Compensation Programs, HRSA, 5600
Fishers Lane, Rockville, Maryland 20857; 3014436634; or ACCV@
HRSA.gov.
DATES:

The ACCV
provides advice and recommendations to the Secretary of HHS on policy, program development, and other issues related to implementation of the National Vaccine Injury Compensation Program VICP and concerning other matters as described under section 2119
of the Public Health Service Act 42
U.S.C. 300aa19.
Since priorities dictate meeting times, be advised that times and agenda items are subject to change. Refer to the ACCV
website listed above for any meeting updates that may occur. For CY 2021
meetings, agenda items may include, but are not limited to updates from the Division of Injury Compensation Programs, Department of Justice, Office of Infectious Disease and HIV/AIDS
Policy HHS, Immunization Safety Office Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases National Institutes of Health and Center for Biologics, Evaluation and Research Food and Drug Administration. Refer to the ACCV
website listed above for all current and updated information concerning the CY
2021 ACCV meetings, including draft agendas and meeting materials that will be posted 5 calendar days before the meetings.
Members of the public will have the opportunity to provide comments.

SUPPLEMENTARY INFORMATION:

E:FRFM28JAN1.SGM

28JAN1